SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-060851
Filing Date
2019-11-07
Accepted
2019-11-07 08:31:23
Documents
63
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919583-1_10q.htm 10-Q 572076
2 EXHIBIT 31.1 tm1919583d1_ex31-1.htm EX-31.1 7689
3 EXHIBIT 31.2 tm1919583d1_ex31-2.htm EX-31.2 7530
4 EXHIBIT 32.1 tm1919583d1_ex32-1.htm EX-32.1 3700
5 EXHIBIT 32.2 tm1919583d1_ex32-2.htm EX-32.2 4052
  Complete submission text file 0001104659-19-060851.txt   4520923

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eyeg-20190930.xml EX-101.INS 1086657
7 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20190930.xsd EX-101.SCH 40053
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20190930_cal.xml EX-101.CAL 39410
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20190930_def.xml EX-101.DEF 143790
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20190930_lab.xml EX-101.LAB 331837
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20190930_pre.xml EX-101.PRE 292875
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 191198252
SIC: 2834 Pharmaceutical Preparations